We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$23.5B
AUM Growth
+$2.05B
Cap. Flow
-$1.67M
Cap. Flow %
-0.01%
Top 10 Hldgs %
21.02%
Holding
3,355
New
222
Increased
1,262
Reduced
1,627
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.74%
2 Financials 4.97%
3 Consumer Discretionary 4.15%
4 Healthcare 3.65%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFLT
3201
DELISTED
Confluent
CFLT
-62,836
Closed -$1.86M
CGC
3202
Canopy Growth
CGC
$431M
-11,326
Closed -$89K
CHGG icon
3203
Chegg
CHGG
$88.9M
-22,664
Closed -$202K
CHH icon
3204
Choice Hotels
CHH
$4.75B
-1,635
Closed -$200K
CIEN icon
3205
Ciena
CIEN
$61.2B
-6,001
Closed -$284K
CIK
3206
Credit Suisse Asset Management Income Fund
CIK
$134M
-19,851
Closed -$51K
COCO icon
3207
Vita Coco
COCO
$3.85B
-12,434
Closed -$324K
CTO
3208
CTO Realty Growth
CTO
$819M
-10,593
Closed -$172K
CTXR icon
3209
Citius Pharmaceuticals
CTXR
$21M
-2,184
Closed -$37K
CURI icon
3210
CuriosityStream
CURI
$166M
-10,125
Closed -$7K
DAR icon
3211
Darling Ingredients
DAR
$10B
-3,973
Closed -$207K
DBP icon
3212
Invesco DB Precious Metals Fund
DBP
$259M
-4,312
Closed -$205K
DGII icon
3213
Digi International
DGII
$3.23B
-9,609
Closed -$259K
DHY
3214
Credit Suisse High Yield Credit Fund
DHY
$239M
-17,334
Closed -$33K
DJP icon
3215
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$825M
-9,885
Closed -$318K
DOCS icon
3216
Doximity
DOCS
$4.45B
-21,101
Closed -$448K
DRSK icon
3217
Aptus Defined Risk ETF
DRSK
$1.54B
-15,893
Closed -$370K
DTIL icon
3218
Precision BioSciences
DTIL
$205M
-508
Closed -$5K
DUOL icon
3219
Duolingo
DUOL
$6.3B
-2,603
Closed -$432K
EJUL icon
3220
Innovator Emerging Markets Power Buffer ETF July
EJUL
$189M
-13,746
Closed -$309K
EOT
3221
Eaton Vance National Municipal Opportunities Trust
EOT
$274M
-12,866
Closed -$209K
EPS icon
3222
WisdomTree US LargeCap Fund
EPS
$1.65B
-38,850
Closed -$1.78M
EQAL icon
3223
Invesco Russell 1000 Equal Weight ETF
EQAL
$844M
-13,938
Closed -$556K
ERH
3224
Allspring Utilities & High Income Fund
ERH
$103M
-16,202
Closed -$142K
ESTA icon
3225
Establishment Labs
ESTA
$2.25B
-6,751
Closed -$331K

Similar funds

Cambridge Investment Research Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Cambridge Investment Research Advisors held 3,355 positions worth $23.5B, up 9.6% from $21.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q4 2023 filing shows 222 new, 1,262 increased, 1,627 reduced and 171 closed positions. Its largest new stake was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $62.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2023 buy was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2023, an estimated $73.8M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $62.7M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $15M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $23.5B portfolio in Q4 2023.
  • Cambridge Investment Research Advisors opened 222 new positions and closed 171 in Q4 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 9.6% quarter-over-quarter to $23.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.